Page last updated: 2024-08-20

monomethylarsonic acid and Acute Promyelocytic Leukemia

monomethylarsonic acid has been researched along with Acute Promyelocytic Leukemia in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Chen, H; Gao, C; Gao, Y; Guo, M; Guo, S; Hai, X; Lin, L; Wang, X; Wu, Z1
Fan, S; Gao, C; Guo, M; Hai, X; Hu, S; Liu, S; Wang, B; Wang, W; Zhou, J1
Černelč, P; Falnoga, I; Podgornik, H; Šlejkovec, Z1
Nelson, R; Self, WT; Talbot, S1
Cao, F; Chen, B; Le, XC; Lu, X; Shen, S; Yuan, C; Zhou, J1
Gong, Z; Le, XC; Lu, X; Wang, Z; Zhou, J1

Trials

1 trial(s) available for monomethylarsonic acid and Acute Promyelocytic Leukemia

ArticleYear
Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
    Chemical research in toxicology, 2004, Volume: 17, Issue:1

    Topics: Adult; Antineoplastic Agents; Arsenic; Arsenic Trioxide; Arsenicals; Arsenites; Cacodylic Acid; Chromatography, High Pressure Liquid; Humans; Injections, Intravenous; Leukemia, Promyelocytic, Acute; Male; Methylation; Middle Aged; Oxidation-Reduction; Oxides

2004

Other Studies

5 other study(ies) available for monomethylarsonic acid and Acute Promyelocytic Leukemia

ArticleYear
Monomethylated arsenic was the Major methylated arsenic in Red blood cells of acute promyelocytic leukemia patients treated with arsenic trioxide.
    Toxicology letters, 2021, Sep-01, Volume: 347

    Topics: Adolescent; Adult; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Biotransformation; Cacodylic Acid; Child; Child, Preschool; Chromatography, High Pressure Liquid; Erythrocytes; Female; Hemoglobins; Humans; Infant; Infant, Newborn; Leukemia, Promyelocytic, Acute; Male; Methylation; Middle Aged; Protein Binding; Spectrometry, Fluorescence; Spectrophotometry, Atomic; Young Adult

2021
Time course of arsenic species in red blood cells of acute promyelocytic leukemia (APL) patients treated with single agent arsenic trioxide.
    Expert review of clinical pharmacology, 2019, Volume: 12, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Arsenic; Arsenic Trioxide; Arsenicals; Cacodylic Acid; Child; Chromatography, High Pressure Liquid; Erythrocytes; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Mass Spectrometry; Middle Aged; Time Factors; Young Adult

2019
Exceptions in patterns of arsenic compounds in urine of acute promyelocytic leukaemia patients treated with As2O3.
    Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2016, Volume: 29, Issue:1

    Topics: Adult; Arsenic Trioxide; Arsenicals; Cacodylic Acid; Female; Humans; Inactivation, Metabolic; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Oxides

2016
Arsenic trioxide and auranofin inhibit selenoprotein synthesis: implications for chemotherapy for acute promyelocytic leukaemia.
    British journal of pharmacology, 2008, Volume: 154, Issue:5

    Topics: Adenocarcinoma; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Arsenites; Auranofin; Cell Line, Tumor; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Leukemia, Promyelocytic, Acute; Lung Neoplasms; Oxides; Protein Biosynthesis; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Messenger; RNA, Small Interfering; Selenium Radioisotopes; Selenoproteins; Sodium Compounds; Sodium Selenite; Thioredoxin Reductase 1

2008
Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
    Analytical and bioanalytical chemistry, 2013, Volume: 405, Issue:6

    Topics: Adult; Antineoplastic Agents; Arsenates; Arsenic Trioxide; Arsenicals; Arsenites; Cacodylic Acid; Chromatography, High Pressure Liquid; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukemia, Promyelocytic, Acute; Male; Methylation; Middle Aged; Oxides; Saliva; Spectrophotometry, Atomic

2013